EMA confirms possible link between J&J COVID vaccine and unusual blood clots

EMA confirms possible link between J&J COVID vaccine and unusual blood clots

The European Medicines Agency’s (EMA’s) safety committee (PRAC) has concluded that a warning about unusual blood clots with low blood platelets should be added...
Moderna jab marks new milestone in NHS vaccination programme

Moderna jab marks new milestone in NHS vaccination programme

A third COVID-19 vaccine has started being rolled out across more than 20 sites, including Reading’s Madejski Stadium and the Sheffield Arena, as the...
MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

MHRA new advice on possible link between COVID-19 Vaccine AstraZeneca and blood clots

The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk...
five-minute breast cancer treatment injection

Twice weekly rapid COVID-19 testing to be available to everyone in England

Access to twice weekly, free, regular, rapid coronavirus (COVID-19) testing from 9 April for everyone in England, the Government has announced. Everyone in England,...
GSK to support manufacture of Novavax’ COVID-19 vaccine

GSK to support manufacture of Novavax’ COVID-19 vaccine

GlaxoSmithKline (GSK) has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up to 60 million...
New lateral flow device distribution service announced for pharmacies

New lateral flow device distribution service announced for pharmacies

A new advanced service – the NHS community pharmacy COVID-19 lateral flow device distribution service – has been added to the NHS Community Pharmacy Contractual Framework (CPCF). The service,...
UK Health Security Agency launched to deal with future threats

UK Health Security Agency launched to deal with future threats

A new UK Health Security Agency (UKHSA) has launched to plan for, prevent and respond to future external health threats such as infectious diseases. The...
The future of digital healthcare

The future of digital healthcare

Building on the huge progress the NHS made during 2020, Gianpiero Celino, Clinical Director, Cegedim Healthcare Solutions, outlines a vision for the future of...
Updated US trial data shows AstraZeneca COVID-19 vaccine is 76% effective

AstraZeneca releases updated US trial data on COVID-19 vaccine

AstraZeneca has released updated information about its COVID-19 vaccine following concern expressed by the Data and Safety Monitoring Board (DSMB) about initial data from...
MSD’s pembrolizumab added to NHSE COVID interim treatment list

MSD’s pembrolizumab added to NHSE COVID interim treatment list

MSD has reached an agreement with NHS England to make pembrolizumab available in England for eligible patients with metastatic MSI-H/dMMR colorectal cancer as an...

Latest articles

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Colin Prentice, Commercial Director at Evolve

Expand and evolve – when specialist services meet

Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...
NHS launches £160m initiative to tackle waiting lists

NHS launches £160m initiative to tackle waiting lists

The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

First Alzheimer’s disease drug candidate designed by AI enters Phase I clinical trials

The world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) is entering Phase I clinical trials, thanks to a successful collaboration...
Chiesi launches new virtual learning and support platform for respiratory nurses

Chiesi launches new virtual learning and support platform for respiratory nurses

A new education platform that brings together nurses on an online community has launched to coincide with International Nurses Day 2021. Chiesi Limited has launched...
NHS launches £160m initiative to tackle waiting lists

NHS launches £160m initiative to tackle waiting lists

The NHS has announced a £160 million initiative to tackle waiting lists and develop a blueprint for elective recovery as early reports show the...
Colin Prentice, Commercial Director at Evolve

Expand and evolve – when specialist services meet

Specialist recruitment and outsourcing consultancy, Evolve, is pleased to announce the integration of Prentice Associates Ltd. The two specialist organisations have both provided recruitment...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription